Search details
1.
Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.
Blood
; 137(10): 1365-1376, 2021 03 11.
Article
in English
| MEDLINE | ID: mdl-32992344
2.
Clonal evolution in chronic lymphocytic leukemia is associated with an unmutated IGHV status and frequently leads to a combination of loss of TP53 and TP53 mutation.
Mol Biol Rep
; 49(12): 12247-12252, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36169893
3.
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.
Blood
; 133(11): 1205-1216, 2019 03 14.
Article
in English
| MEDLINE | ID: mdl-30602617
4.
Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia.
Haematologica
; 104(2): 360-369, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30262567
5.
Identification of prognostic parameters in CLL with no abnormalities detected by chromosome banding and FISH analyses.
Br J Haematol
; 183(1): 47-59, 2018 10.
Article
in English
| MEDLINE | ID: mdl-30022491
6.
Gain of chromosome 21 or amplification of chromosome arm 21q is one mechanism for increased ERG expression in acute myeloid leukemia.
Genes Chromosomes Cancer
; 55(2): 148-57, 2016 Feb.
Article
in English
| MEDLINE | ID: mdl-26542308
7.
Investigation of 305 patients with myelodysplastic syndromes and 20q deletion for associated cytogenetic and molecular genetic lesions and their prognostic impact.
Br J Haematol
; 164(6): 822-33, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24372512
8.
Detection and characterization of homozygosity of mutated CALR by copy neutral loss of heterozygosity in myeloproliferative neoplasms among cases with high CALR mutation loads or with progressive disease.
Haematologica
; 104(5): e187-e190, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30409794
9.
The mutational landscape of 18 investigated genes clearly separates four subtypes of myelodysplastic/myeloproliferative neoplasms.
Haematologica
; 103(5): e192-e195, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29700173
10.
T cell receptor gene repertoire profiles in subgroups of patients with chronic lymphocytic leukemia bearing distinct genomic aberrations.
Front Oncol
; 13: 1097942, 2023.
Article
in English
| MEDLINE | ID: mdl-36816924
11.
Acute myeloid leukemias with ring sideroblasts show a unique molecular signature straddling secondary acute myeloid leukemia and de novo acute myeloid leukemia.
Haematologica
; 102(4): e125-e128, 2017 04.
Article
in English
| MEDLINE | ID: mdl-28057736
12.
Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration.
Leukemia
; 36(2): 394-402, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34376804
13.
Prognostic relevance of RUNX1 mutations in T-cell acute lymphoblastic leukemia.
Haematologica
; 96(12): 1874-7, 2011 Dec.
Article
in English
| MEDLINE | ID: mdl-21828118
14.
Accumulation of adverse prognostic markers worsens prognosis in chronic lymphocytic leukaemia.
Br J Haematol
; 168(1): 153-6, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25135300
15.
Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations.
Haematologica
; 100(4): e125-7, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25527566
16.
Cytogenetic and molecular genetic characterization of KMT2A-PTD positive acute myeloid leukemia in comparison to KMT2A-Rearranged acute myeloid leukemia.
Cancer Genet
; 240: 15-22, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31698332
17.
Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.
Haematologica
; 99(12): e244-6, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25239264
18.
Molecular characterization of AML with RUNX1-RUNX1T1 at diagnosis and relapse reveals net loss of co-mutations.
Hemasphere
; 3(1): e178, 2019 Feb.
Article
in English
| MEDLINE | ID: mdl-31723813
19.
High frequencies of SF3B1 and JAK2 mutations in refractory anemia with ring sideroblasts associated with marked thrombocytosis strengthen the assignment to the category of myelodysplastic/myeloproliferative neoplasms.
Haematologica
; 98(2): e15-7, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-22929973
20.
NPM1 mutated AML can relapse with wild-type NPM1: persistent clonal hematopoiesis can drive relapse.
Blood Adv
; 2(22): 3118-3125, 2018 11 27.
Article
in English
| MEDLINE | ID: mdl-30455361